デフォルト表紙
市場調査レポート
商品コード
1405879

米国の頭蓋顎顔面デバイス市場規模、シェア、動向分析レポート:製品別、材料別、用途別、セグメント別予測、2023-2030年

U.S. Craniomaxillofacial Devices Market Size, Share & Trends Analysis Report By Product, By Material (Metal, Bio Absorbable Material, Ceramics), By Application (Neurosurgery, Plastic Surgery), And Segment Forecasts, 2023 - 2030

出版日: | 発行: Grand View Research | ページ情報: 英文 120 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
米国の頭蓋顎顔面デバイス市場規模、シェア、動向分析レポート:製品別、材料別、用途別、セグメント別予測、2023-2030年
出版日: 2023年12月19日
発行: Grand View Research
ページ情報: 英文 120 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

米国の頭蓋顎顔面デバイス市場の成長と動向:

Grand View Research社の最新レポートによると、米国の頭蓋顎顔面デバイス市場規模は2030年までに21億5,000万米ドルに達し、2023年から2030年までのCAGRは9.2%で拡大すると予測されています。

スポーツ傷害や交通事故による顔面骨折の発生率の上昇、美意識の高まりが製品需要を促進する主な要因です。顎関節置換術の需要は、高い採用率により予測期間中に上昇すると予測されています。

外傷による骨折やその他の頭蓋顎顔面損傷により、顔面や頭蓋骨の手術が必要な場合、患者は頭蓋顎顔面手術を頻繁に受ける。頭蓋顎顔面器具は、美容と顔面再建に使用されます。この器具は主に脳神経外科、顎矯正外科、歯科口腔外科、形成外科で使用されています。

COVID-19の発生は、CMF器具の市場に悪影響を及ぼしました。選択的手術用の製品を製造するメーカーは、生産の減速、労働時間の短縮、レイオフの結果、売上が大幅に減少しました。COVID-19問題は、神経製品ラインに最も大きな影響を与えました。必要のない手術が中止されたため、注文が遅れ、消耗品の売上が減少しました。形成外科医を常駐させるコビッド・ケアセンターが作られ、緊急時のみ形成外科で対応することになった。

しかし、パンデミック後の各企業の売上収益を見ると、順調に回復しています。例えば、ジョンソン・エンド・ジョンソンの財務報告書(2021年)によると、外科、インターベンショナル・ソリューションズ、視覚、整形外科を含む全事業において、医療機器の世界調整後営業売上高は16.8%増加したが、これは主にCOVID-19の影響からの市場の回復と、それに伴う前年の医療処置の延期に起因します。

米国の頭蓋顎顔面デバイス市場レポートハイライト:

  • CMFプレートおよびスクリュー固定装置は、2022年に最大の製品タイプセグメントとして台頭し、70%以上の収益シェアを占める。
  • 生体吸収性材料は予測期間中に最も急成長する材料セグメントと予測されます。
  • 同市場で事業を展開する主要企業には、Stryker Corporation、Medtronic Plc、KLS Martin L.P.、Medartis AG、Johnson &Johnson、W. L. Gore &Associates, Inc、TMJ Concepts、Integra LifeSciences、OsteoMed L.P.、Aesculap Implant Systems, Inc、Zimmer-Biomet Inc.などがあります。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 頭蓋顎顔面デバイス市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 普及と成長の見通しマッピング
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 頭蓋顎顔面デバイス市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 頭蓋顎顔面デバイス:製品の推定・動向分析

  • 頭蓋顎顔面デバイス市場:重要なポイント
  • 頭蓋顎顔面デバイス市場:動向と市場シェア分析、2022年および2030年
  • 頭蓋皮弁の固定
  • CMFディストラクション
  • 顎関節置換術
  • 胸部固定
  • 骨移植片代替品
  • CMFプレートとネジの固定

第5章 頭蓋顎顔面デバイス:材料の推定・動向分析

  • 頭蓋顎顔面デバイス市場:重要なポイント
  • 頭蓋顎顔面デバイス市場:動向と市場シェア分析、2022年および2030年
  • 金属
  • 生体吸収性材料
  • セラミックス

第6章 頭蓋顎顔面デバイス:用途の推定・動向分析

  • 頭蓋顎顔面デバイス市場:重要なポイント
  • 頭蓋顎顔面デバイス市場:動向と市場シェア分析、2022年および2030年
  • 脳神経外科
  • 顎矯正および歯科外科
  • 形成外科

第7章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 市場参入企業の分類
    • Stryker Corporation
    • Medtronic Plc
    • KLS Martin Group
    • Medartis AG
    • Johnson & Johnson
    • W. L. Gore & Associates, Inc.
    • TMJ Concepts
    • Integra LifeSciences
    • OsteoMed L.P.
    • Aesculap Implant Systems, LLC
    • Zimmer Biomet Inc.
図表

List of Tables

  • Table 1 Table 1 List of Abbreviations
  • Table 2 Table 2 List of Secondary Sources
  • Table 3 Table 3 U.S. Craniomaxillofacial Devices Market, by Product, 2018 - 2030 (USD Million)
  • Table 4 Table 4 U.S. Craniomaxillofacial Devices Market, by Material, 2018 - 2030 (USD Million)
  • Table 5 U.S. Craniomaxillofacial Devices Market, by Application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Craniomaxillofacial devices: Market outlook
  • Fig. 9 Craniomaxillofacial devices: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 U.S. Craniomaxillofacial devices market driver impact
  • Fig. 15 U.S. Craniomaxillofacial devices market restraint impact
  • Fig. 16 U.S. Craniomaxillofacial devices market strategic initiatives analysis
  • Fig. 17 U.S. Craniomaxillofacial devices market: Product movement analysis
  • Fig. 18 U.S. Craniomaxillofacial devices market: Product outlook and key takeaways
  • Fig. 19 Cranial flap fixation market estimates and forecasts, 2018 - 2030
  • Fig. 20 CMF distraction market estimates and forecasts, 2018 - 2030
  • Fig. 21 Temporomandibular joint replacement market estimates and forecasts, 2018 - 2030
  • Fig. 22 Thoracic fixation market estimates and forecasts, 2018 - 2030
  • Fig. 23 Bone graft substitute market estimates and forecasts, 2018 - 2030
  • Fig. 24 CMF plate and screw fixation market estimates and forecasts, 2018 - 2030
  • Fig. 25 U.S. Craniomaxillofacial devices market: Material movement analysis
  • Fig. 26 U.S. Craniomaxillofacial devices market: Material outlook and key takeaways
  • Fig. 27 Metal market estimates and forecasts, 2018 - 2030
  • Fig. 28 Bioabsorbable material market estimates and forecasts, 2018 - 2030
  • Fig. 29 Ceramics market estimates and forecasts, 2018 - 2030
  • Fig. 30 U.S. Craniomaxillofacial devices market: Application movement analysis
  • Fig. 31 U.S. Craniomaxillofacial devices market: Application outlook and key takeaways
  • Fig. 32 Neurosurgery market estimates and forecasts, 2018 - 2030
  • Fig. 33 Orthognathic and dental surgery market estimates and forecasts, 2018 - 2030
  • Fig. 34 Plastic surgery market estimates and forecasts, 2018 - 2030
目次
Product Code: GVR-2-68038-712-4

U.S. Craniomaxillofacial Devices Market Growth & Trends:

The U.S. craniomaxillofacial devices market size is expected to reach USD 2.15 billion by 2030, expanding at a CAGR of 9.2% from 2023 to 2030, according to a new report by Grand View Research, Inc. The rising incidence of facial fractures due to sports injuries and road accidents, and increasing aesthetic consciousness are the key factors driving the product demand. The demand for Temporomandibular Joint Replacement is projected to witness a rise during the forecast period due to high adoption.

When a patient needs face or cranial bone surgery because of trauma-related fractures or other craniomaxillofacial injuries, they frequently undergo craniomaxillofacial surgery. Craniomaxillofacial devices are used in aesthetics and facial reconstruction. The devices mostly find application in neurosurgery, orthognathic and dental surgery, and plastic surgery.

The COVID-19 outbreak had a detrimental effect on the market for CMF devices since the manufacturers of products for elective procedures saw a significant drop in sales, as a result of production slowdown, a reduction in working hours, and layoffs. The COVID-19 problem had the greatest effect on the neurological product line. Due to the suspension of non-essential surgeries, orders were delayed and consumable sales were decreased. Covid Care Centers were created to house plastic surgeons, and only emergencies were treated with plastic surgery.

However, the post-pandemic period has seen a good recovery looking at the sales revenue generated by the companies. For instance, according to Johnson and Johnson financial report 2021, In all of its businesses, including Surgery, Interventional Solutions, Vision, and Orthopaedics, Medical Devices worldwide adjusted operational sales increased by 16.8%, mainly attributable to the market's recovery from COVID-19 impacts and the resulting postponement of medical procedures in the prior year.

U.S. Craniomaxillofacial Devices Market Report Highlights:

  • CMF Plate and Screw fixation devices emerged as the largest product type segment in 2022 accounting for the largest revenue share of over 70%
  • Bioabsorbable materials are anticipated to be the fastest-growing material segment over the forecast period
  • Some of the key players operating in the market include Stryker Corporation; Medtronic Plc; KLS Martin L.P; Medartis AG; Johnson & Johnson; W. L. Gore & Associates, Inc; TMJ Concepts; Integra LifeSciences; OsteoMed L.P.; Aesculap Implant Systems, Inc; Zimmer-Biomet Inc.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Material
    • 1.1.3. Application
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Material outlook
    • 2.2.3. Application outlook
  • 2.3. Competitive Insights

Chapter 3. Craniomaxillofacial Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Craniomaxillofacial Devices Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Craniomaxillofacial Devices : Product Estimates & Trend Analysis

  • 4.1. Craniomaxillofacial Devices Market: Key Takeaways
  • 4.2. Craniomaxillofacial Devices Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Cranial Flap Fixation
    • 4.3.1. Cranial flap fixation market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. CMF Distraction
    • 4.4.1. CMF distraction market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Temporomandibular Joint Replacement
    • 4.5.1. Temporomandibular joint replacement market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Thoracic Fixation
    • 4.6.1. Thoracic fixation market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.7. Bone Graft Substitute
    • 4.7.1. Bone graft substitute market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.8. CMF Plate and Screw Fixation
    • 4.8.1. CMF plate and screw fixation market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Craniomaxillofacial Devices : Material Estimates & Trend Analysis

  • 5.1. Craniomaxillofacial Devices Market: Key Takeaways
  • 5.2. Craniomaxillofacial Devices Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Metal
    • 5.3.1. Metal market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Bioabsorbable material
    • 5.4.1. Bioabsorbable material market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Ceramics
    • 5.5.1. Ceramics market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Craniomaxillofacial Devices : Application Estimates & Trend Analysis

  • 6.1. Craniomaxillofacial Devices Market: Key Takeaways
  • 6.2. Craniomaxillofacial Devices Market: Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Neurosurgery
    • 6.3.1. Neurosurgery market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. Orthognathic and Dental Surgery
    • 6.4.1. Orthognathic and dental surgery market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Plastic surgery
    • 6.5.1. Plastic surgery market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Market Participant Categorization
    • 7.2.1. Stryker Corporation
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Medtronic Plc
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. KLS Martin Group
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Medartis AG
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. Johnson & Johnson
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. W. L. Gore & Associates, Inc.
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. TMJ Concepts
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Integra LifeSciences
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. OsteoMed L.P.
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives
    • 7.2.10. Aesculap Implant Systems, LLC
      • 7.2.10.1. Company overview
      • 7.2.10.2. Financial performance
      • 7.2.10.3. Product benchmarking
      • 7.2.10.4. Strategic initiatives
    • 7.2.11. Zimmer Biomet Inc.
      • 7.2.11.1. Company overview
      • 7.2.11.2. Financial performance
      • 7.2.11.3. Product benchmarking
      • 7.2.11.4. Strategic initiatives